Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Current Opinion in Neurology|October 1, 1994
Gene therapy for muscle diseasesD D Coovert, A H BurghesHuman Molecular Genetics|September 27, 2000
Animal models of spinal muscular atrophyU R Monani, D D Coovert, A H BurghesNeurogenetics|November 21, 2000
The survival motor neuron (SMN) protein: effect of exon loss and mutation on protein localizationT T Le, D D Coovert, U R Monani, et al.American Journal of Human Genetics|May 1, 1992
Somatic reversion/suppression in Duchenne muscular dystrophy (DMD): evidence supporting a frame-restoring mechanism in rare dystrophin-positive fibersC J Klein, D D Coovert, D E Bulman, et al.Neurology|May 1, 1991
Dystrophin expression and somatic reversion in prednisone-treated and untreated Duchenne dystrophy. CIDD Study GroupK L Burrow, D D Coovert, C J Klein, et al.American Journal of Veterinary Research|February 24, 2001
Use of western immunoblot for evaluation of myocardial dystrophin, alpha-sarcoglycan, and beta-dystroglycan in dogs with idiopathic dilated cardiomyopathyA W Spier, K M Meurs, D D Coovert, et al.Human Molecular Genetics|June 1, 1993
Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophyA V Winnard, C J Klein, D D Coovert, et al.Human Molecular Genetics|December 6, 2001
Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patientsC Andreassi, J Jarecki, J Zhou, et al.Human Molecular Genetics|August 1, 1997
The survival motor neuron protein in spinal muscular atrophyD D Coovert, T T Le, P E McAndrew, et al.Human Molecular Genetics|February 3, 2000
The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophyU R Monani, M Sendtner, D D Coovert, et al.Pageof 1